| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,328 |
15,723 |
$594K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,375 |
3,109 |
$164K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,098 |
2,893 |
$160K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,970 |
1,856 |
$129K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,156 |
1,031 |
$117K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,469 |
2,194 |
$105K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,244 |
2,027 |
$102K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
777 |
731 |
$37K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
742 |
630 |
$30K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,151 |
1,078 |
$29K |
| 90670 |
|
2,077 |
1,979 |
$21K |
| 90686 |
|
1,224 |
1,105 |
$14K |
| 90647 |
|
1,264 |
1,221 |
$14K |
| 90723 |
|
1,264 |
1,227 |
$12K |
| 99381 |
|
226 |
218 |
$12K |
| 99173 |
|
903 |
832 |
$12K |
| 90633 |
|
1,018 |
962 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
854 |
423 |
$10K |
| 90681 |
|
893 |
843 |
$9K |
| 90697 |
|
418 |
384 |
$6K |
| 74018 |
|
196 |
178 |
$5K |
| 87807 |
|
420 |
386 |
$5K |
| 92551 |
|
640 |
590 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
76 |
68 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
96 |
91 |
$4K |
| 90677 |
|
340 |
311 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
833 |
772 |
$2K |
| 90688 |
|
202 |
195 |
$2K |
| 90710 |
|
161 |
155 |
$2K |
| 90707 |
|
153 |
152 |
$2K |
| 90700 |
|
146 |
140 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
140 |
133 |
$2K |
| 90685 |
|
156 |
151 |
$1K |
| 90716 |
|
129 |
128 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
31 |
31 |
$1K |
| 71045 |
Radiologic examination, chest; single view |
58 |
55 |
$1K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
31 |
28 |
$1K |
| 90696 |
|
104 |
102 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
50 |
44 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
466 |
381 |
$1K |
| 90656 |
|
95 |
92 |
$620.35 |
| 71020 |
|
15 |
12 |
$486.20 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
14 |
12 |
$425.43 |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
230 |
202 |
$353.60 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
99 |
91 |
$253.44 |
| 96127 |
|
101 |
80 |
$235.46 |
| 90651 |
|
16 |
14 |
$183.96 |
| 90734 |
|
14 |
12 |
$157.68 |
| 90381 |
|
13 |
12 |
$144.54 |
| 81003 |
|
71 |
62 |
$140.80 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
32 |
26 |
$52.67 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
47 |
34 |
$0.00 |
| 90687 |
|
13 |
13 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
12 |
$0.00 |